Akebia Therapeutics Inc. (AKBA) Stock Forecast & Predictions

Akebia Therapeutics Inc. AKBA: $3.08

245 1st St, Cambridge, Massachusetts, US. | Sector: Manufacturing | Exchange: NASDAQ/NMS (GLOBAL MARKET) | Web: https://akebia.com/

  • Market Cap$0.46B
  • Change (52 Weeks)-60.51%
  • Low (52 Weeks)$2.09
  • Akebia Therapeutics Inc. (AKBA) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 12.50% are on Buy, 37.50% on Sell, and 50.00% Neutral.

    According to the market data, Akebia Therapeutics Inc. (AKBA) stock price is $3.08 and the 52 weeks low is $2.09, which means the Akebia Therapeutics Inc. stock price is down -60.51% in the last 12 months.

    Akebia Therapeutics Inc. (AKBA) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 12.50% are indicating that AKBA Stock price might rise further, 37.50% indicating that AKBA Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall AKBA stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Akebia Therapeutics Inc. (AKBA) Stock Forecast By Analysts


    Strong Buy
    Analysts Recommendations for Akebia Therapeutics Inc. (AKBA) is based on 14 Institutional Analyst Ratings where 57.14% are on Strong Buy, 21.43% on Moderate Buy, 14.29% remains on Hold, 0.00% are on Moderate Sell and 7.14% are on Strong Sell.

    Out of 14 Institutional Analysts, majority recommended AKBA stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Akebia Therapeutics Inc..

    Akebia Therapeutics Inc. (AKBA) Stock Price Prediction By Analysts


    HighLowAverage
    $10.50$3.03$6.85
    $6.85122.36% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for AKBA set by the institutional analysts is $6.85 where High Estimate is $10.50, Median $6.12 and Low $3.03.

    The average price target for AKBA by Institutional Analysts is $6.85, which is 122.36% Upside from the current price. So according to the Institutional Analysts, AKBA Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Akebia Therapeutics Inc. (AKBA) Stock Forecast Based on News Sentiment


    Neutral
    Based on 1 articles published Last Week, where 50.00% are Bullish and 50.00% are Bearish.

    According to the news articles published last week, journalists and bloggers had a mixed sentiment of AKBA consisting of positive and negative, it shows that Akebia Therapeutics Inc. had a neutral news coverage.

    Neutral news coverage usually doesn't affect short-term price of a stock, so AKBA stock price most likey won't have any reaction to last weeks news coverage.

    Akebia Therapeutics Inc. (AKBA) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    HC Wainwright & Co.BuyMaintained
    Cantor FitzgeraldOverweightInitiated
    JP MorganUnderweightDowngraded
    HC Wainwright & Co.BuyMaintained
    Morgan StanleyEqual-WeightMaintained
    HC Wainwright & Co.BuyMaintained
    BTIGBuyMaintained
    Morgan StanleyEqual-WeightMaintained
    Morgan StanleyEqual-WeightMaintained
    MizuhoBuyMaintained
    JP MorganOverweightMaintained
    H.C. WainwrightBuyMaintained
    NeedhamBuyMaintained
    MizuhoBuyReiterated
    JP MorganOverweightMaintained
    H.C. WainwrightBuyMaintained
    H.C. WainwrightBuyMaintained
    JP MorganOverweightInitiated
    CitigroupNeutralInitiated
    Raymond JamesOutperformInitiated
    PiperJaffrayOverweightInitiated
    BTIG ResearchBuyInitiated
    MizuhoBuyInitiated
    RBC CapitalSector PerformInitiated
    Aegis CapitalBuyInitiated
    H.C. WainwrightBuyMaintained
    JMP SecuritiesMarket OutperformMaintained
    Credit SuisseNeutralInitiated
    H.C. WainwrightBuyInitiated
    Morgan StanleyOverweightUpgraded
    Brean CapitalBuyMaintained
    Morgan StanleyEqual-WeightInitiated
    JMP SecuritiesOutperformInitiated
    Brean CapitalBuyInitiated
    NeedhamBuyInitiated
    UBSBuyInitiated
    NomuraBuyInitiated
    Morgan StanleyOverweightInitiated
    Credit SuisseOutperformInitiated

    Akebia Therapeutics Inc. (AKBA) Stock Earning Per Share (EPS) Forecast / Estimate


    $-0.328
    The average consensus EPS for AKBA is $-0.328 with a high estimate of $-0.221 and Low of $-0.470 for the period 2021-06-30 and based on 9 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $-0.42$-0.175952020-09-30


    The latest average Earning Per Share Estimate for Akebia Therapeutics Inc. is $-0.33, which is higher than AKBA's last EPS, $-0.42. This means that Analysts are expecting Akebia Therapeutics Inc. to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of Akebia Therapeutics Inc..

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $-0.42$-0.175952020-09-30
    $-0.44$-0.507452020-06-30
    $-0.47$-0.6311252020-03-31
    $-0.79$-0.481952019-12-31
    $-0.46$-0.43422422019-09-30
    $-0.49$-0.3276752019-06-30
    $-0.62$-0.40838762019-03-31
    $-0.23$-0.24309662018-12-31
    $-0.46$-0.65425859999999992018-09-30
    $-0.6$-0.51728282018-06-30
    $-0.48$-0.6030752018-03-31
    $0.25$-0.358132199999999962017-12-31
    $-0.49$-0.51728282017-09-30
    $-0.53$-0.88400340000000012017-06-30
    $-1.15$-0.397800000000000042017-03-31
    $-0.99$0.782342016-12-31
    $-0.96$-1.11384000000000022016-09-30
    $-0.95$-0.58139999999999992016-06-30
    $-0.7$-0.43352016-03-31
    $-0.66$-0.28181582015-12-31
    $-0.68$-0.528362015-09-30
    $-0.4$-0.51816000000000012015-06-30
    $-0.53$-0.58139999999999992015-03-31
    $-0.52$-0.667592014-12-31
    $-0.47$-0.461552014-09-30
    $-0.39$-0.527342014-06-30
    $-4.35$-0.38762014-03-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).